Clinical Significance of Positive Surgical Margin after Radical Prostatectomy according to Pathological Stage.
10.22465/kjuo.2016.14.3.159
- Author:
In Jae LEE
1
;
Jong Jin OH
;
Tae Jin KIM
;
Byeong Do SONG
;
Sangchul LEE
;
Sung Kyu HONG
;
Sang Eun LEE
;
Seok Soo BYUN
Author Information
1. Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea. ssbyun@snubh.org
- Publication Type:Original Article
- Keywords:
Prostate neoplasms;
Surgical margin
- MeSH:
Follow-Up Studies;
Humans;
Kaplan-Meier Estimate;
Neoplasm Grading;
Passive Cutaneous Anaphylaxis;
Prostate-Specific Antigen;
Prostatectomy*;
Prostatic Neoplasms;
Recurrence;
Retrospective Studies;
Survival Rate
- From:Korean Journal of Urological Oncology
2016;14(3):159-164
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: The purpose of this study was to investigate the positive surgical margin (PSM) as a predictive factor of biochemical recurrence (BCR) in prostate cancer (PCa) patients after radical prostatectomy (RP) according to each pathological stage. MATERIALS AND METHODS: The records of 3,037 patients receiving RP were retrospectively reviewed. All patients were divided into 6 groups depending on pathological stage and presence of PSM. Cox proportional hazard analyses were performed to show the significance of PSM in all patients and in subgroup patients (T2, T3a, and T3b). The Kaplan-Meier analysis showed BCR-free survival rate of each group. RESULTS: Among total 3.307 patients, the mean age was 65.89 years and PSM rate was 18.7%. During the 47.1 months, 550 patients had experienced BCR (26.2%). According to groups, prostate-specific antigen, Gleason score, and BCR were significantly different. Ten-year BCR-free survival rate was 87.1% (T2R0), 65.9% (T2R1), 60.1% (T3aR0), 43.0% (T3aR1), 20.8% (T3bR0), and 5.8% (T3bR1). Each group had statistical differences with BCR-free survival except T2R1 and T3aR0 (p=0.090). PSM was significant in multivariate Cox analyses in total patients (hazard ratio, 2.091; 95% confidence interval, 1.724–2.536; p<0.001) and in all subgroup with each stages. CONCLUSIONS: PSM is a significant predictor to BCR after RP in all PCa patients and in each stage. T2R1 PCa had a similar BCR-free survival rate to T3R0 patients during long-term follow-up, therefore careful management to T2R1 PCa as T3 should be necessary.
